 |
|
Two-sample Mendelian randomization study for schizophrenia and breast cancer
Soyeon Kim, Kiwon Kim, Woojae Myung, Hyewon Lee, Ho Kim, Doh Kwan Kim, Hong-Hee Won
Precis Future Med. 2020;4(1):21-30. Published online 2020 Feb 11 DOI: https://doi.org/10.23838/pfm.2019.00093
|
|
Citations to this article as recorded by
 Genome-wide studies of comorbidity of somatic and mental diseases
V.E. Golimbet, T.P. Klyushnik
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2023; 123(4): 60. CrossRef Genome-Wide Studies of the Comorbidity of Somatic and Mental Diseases
V. E. Golimbet, T. P. Klyushnik
Neuroscience and Behavioral Physiology.2023; 53(8): 1386. CrossRef Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
Kai Yuan, Weichen Song, Zhe Liu, Guan Ning Lin, Shunying Yu
Biology.2022; 11(9): 1345. CrossRef Applications of Mendelian randomization in psychiatry: a comprehensive systematic review
Luigi F. Saccaro, Simone Gasparini, Grazia Rutigliano
Psychiatric Genetics.2022; 32(6): 199. CrossRef Sex differences in schizophrenia relevant to clinical care
Mary V. Seeman
Expert Review of Neurotherapeutics.2021; 21(4): 443. CrossRef
|